MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.

MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.

Item
http://www.wikidata.org/entity/Q48595565
From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer DrugsmiR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma.Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer.Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2.Are IL18RAP gene polymorphisms associated with body mass regulation? A cross-sectional study.Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway.Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.The Network of Non-coding RNAs in Cancer Drug Resistance
P2860

MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.

Item
http://www.wikidata.org/entity/Q48595565
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@en
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@nl
type
label
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@en
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@nl
prefLabel
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@en
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698